| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3296521 | Gastroenterology | 2010 | 14 Pages |
Abstract
Once-daily dosing of delayed-release mesalamine at doses of 1.6-2.4 g/day was shown to be as effective as twice-daily dosing for maintenance of clinical remission in patients with UC.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
William J. Sandborn, Joshua Korzenik, Bret Lashner, Jonathan A. Leighton, Uma Mahadevan, James F. Marion, Michael Safdi, Charles A. Sninsky, Raman M. Patel, Keith A. Friedenberg, Preston Dunnmon, David Ramsey, Sunanda Kane,